# AI ê¸°ë°˜ CKD-CVD ì‹ ì•½ ë°œê²¬ íŒŒì´í”„ë¼ì¸

ì™„ì „íˆ ì‘ë™í•˜ëŠ” AI ì‹ ì•½ ê°œë°œ ì‹œìŠ¤í…œì´ êµ¬ì¶•ë˜ì—ˆìŠµë‹ˆë‹¤!

## ğŸ“ í”„ë¡œì íŠ¸ êµ¬ì¡°

```
drug_discovery/
â”œâ”€â”€ phase1_literature_mining.py    # ë¬¸í—Œ ë§ˆì´ë‹ ë° ì§€ì‹ ì¶”ì¶œ
â”œâ”€â”€ phase2_molecular_docking.py    # ë‹¨ë°±ì§ˆ êµ¬ì¡° & ë¶„ì ë„í‚¹
â”œâ”€â”€ phase3_deep_learning.py        # ë”¥ëŸ¬ë‹ í‰ê°€ (GNN + Transformer)
â”œâ”€â”€ run_pipeline.py                # ì „ì²´ íŒŒì´í”„ë¼ì¸ í†µí•© ì‹¤í–‰
â””â”€â”€ README.md                      # ì´ íŒŒì¼

data/
â”œâ”€â”€ literature/                    # ìˆ˜ì§‘ëœ ë…¼ë¬¸ ë°ì´í„°
â”œâ”€â”€ protein_structures/            # ë‹¨ë°±ì§ˆ PDB íŒŒì¼
â”œâ”€â”€ docking_results/              # ë„í‚¹ ì‹œë®¬ë ˆì´ì…˜ ê²°ê³¼
â””â”€â”€ ml_evaluations/               # ML í‰ê°€ ê²°ê³¼

results/
â””â”€â”€ run_YYYYMMDD_HHMMSS/         # ì‹¤í–‰ ê²°ê³¼
    â”œâ”€â”€ FINAL_REPORT.md          # ìµœì¢… ë³´ê³ ì„œ
    â”œâ”€â”€ final_ranking.csv        # í›„ë³´ ë¬¼ì§ˆ ìˆœìœ„
    â””â”€â”€ visualizations.png       # ì‹œê°í™”
```

## ğŸš€ ì‹¤í–‰ ë°©ë²•

### 1. í™˜ê²½ ì„¤ì •

```bash
pip install torch torchvision
pip install requests pandas numpy matplotlib seaborn
pip install torch-geometric  # optional, for GNN
```

### 2. ì „ì²´ íŒŒì´í”„ë¼ì¸ ì‹¤í–‰

```bash
cd drug_discovery
python run_pipeline.py
```

### 3. ê°œë³„ Phase ì‹¤í–‰

```bash
# Phase 1ë§Œ
python phase1_literature_mining.py

# Phase 2ë§Œ
python phase2_molecular_docking.py

# Phase 3ë§Œ
python phase3_deep_learning.py
```

## ğŸ“Š íŒŒì´í”„ë¼ì¸ íë¦„

```
[Phase 1: ë¬¸í—Œ ë§ˆì´ë‹]
     â†“
  PubMed API â†’ 100+ ë…¼ë¬¸ ìˆ˜ì§‘
     â†“
  NLP ì¶”ì¶œ â†’ íƒ€ê²Ÿ ë‹¨ë°±ì§ˆ & ì¹˜ë£Œ ë¶„ì
     â†“
[Phase 2: ë¶„ì ë„í‚¹]
     â†“
  PDB/AlphaFold â†’ ë‹¨ë°±ì§ˆ 3D êµ¬ì¡°
     â†“
  Virtual Screening â†’ ê²°í•©ë ¥ ê³„ì‚°
     â†“
[Phase 3: ë”¥ëŸ¬ë‹ í‰ê°€]
     â†“
  GNN â†’ ë¶„ì íŠ¹ì„± ì˜ˆì¸¡
     â†“
  Transformer â†’ ADMET í‰ê°€
     â†“
[í†µí•© & ìµœì¢… ìˆœìœ„]
     â†“
  Top 10 í›„ë³´ ë¬¼ì§ˆ ë„ì¶œ!
```

## ğŸ¯ í•µì‹¬ íƒ€ê²Ÿ

1. **NF-ÎºB p65** - ì—¼ì¦ ê²½ë¡œ
2. **TGF-Î² Receptor I** - ì„¬ìœ í™” ê²½ë¡œ
3. **NOX4** - ì‚°í™” ìŠ¤íŠ¸ë ˆìŠ¤
4. **VCAM1** - ë‚´í”¼ ê¸°ëŠ¥
5. **Cyclophilin D** - ë¯¸í† ì½˜ë“œë¦¬ì•„ ë³´í˜¸

## ğŸ’Š ì˜ˆìƒ í›„ë³´ ë¬¼ì§ˆ

- Metformin (repurposing)
- Bardoxolone
- Pirfenidone
- ì‹ ê·œ í™”í•©ë¬¼ Compound-A, B, C

## ğŸ“ˆ í‰ê°€ ì§€í‘œ

### ì¢…í•© ì ìˆ˜ êµ¬ì„±
- **Binding Affinity** (40%): íƒ€ê²Ÿ ê²°í•©ë ¥
- **ADMET** (30%): ì•½ë¬¼ë™íƒœí•™
- **Drug-likeness** (20%): Lipinski, QED
- **Safety** (10%): ë…ì„± ìœ„í—˜

### ì¶œë ¥ ê²°ê³¼

- `final_ranking.csv`: ìˆœìœ„, ì ìˆ˜, ì¶”ì²œ ë“±ê¸‰
- `FINAL_REPORT.md`: ìƒì„¸ ë³´ê³ ì„œ
- `visualizations.png`: ì°¨íŠ¸ ë° ê·¸ë˜í”„

## ğŸ”¬ ë‹¤ìŒ ë‹¨ê³„

1. **Top 3 í™”í•™ì  í•©ì„±** ($1,500-3,000, 2-3ì£¼)
2. **In Vitro ê²€ì¦** (HK-2, HUVEC, 4-8ì£¼)
3. **ë™ë¬¼ ì‹¤í—˜** (CKD ë§ˆìš°ìŠ¤, 3-6ê°œì›”)
4. **ì„ìƒ ì§„ì…** (IND ì‹ ì²­)

## âš ï¸ ì£¼ì˜ì‚¬í•­

ì´ ì‹œìŠ¤í…œì€ **In Silico** (ì»´í“¨í„° ì‹œë®¬ë ˆì´ì…˜) ê¸°ë°˜ì…ë‹ˆë‹¤.

ì‹¤ì œ ì‹ ì•½ ê°œë°œì„ ìœ„í•´ì„œëŠ”:
- âœ… ì‹¤í—˜ ê²€ì¦ í•„ìˆ˜
- âœ… ë…ì„± í‰ê°€ í•„ìˆ˜
- âœ… ì„ìƒì‹œí—˜ ìŠ¹ì¸ í•„ìš”

## ğŸ“š ì°¸ê³  ìë£Œ

- PubMed API: https://www.ncbi.nlm.nih.gov/home/develop/api/
- PDB: https://www.rcsb.org/
- AlphaFold: https://alphafold.ebi.ac.uk/
- AutoDock Vina: http://vina.scripps.edu/

## ğŸ‘¨â€ğŸ’» ê°œë°œì

- **Mela-Exosome AI Team**
- **Version**: 1.0
- **Date**: 2025-12-27

---

**ğŸ‰ AIë¡œ CKD-CVD ì¹˜ë£Œì œë¥¼ ì°¾ì•„ë´…ì‹œë‹¤!**
